Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials
Journal of Drugs in Dermatology · 01.11.2026 · 25 (11) · 1039-1044
DOI: 10.36849/jdd.10039 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.10.2026. Verfasst von Lucie Joerg und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Lupus Erythematosus, Systemic, Protein Kinase Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Joerg, L., Stolyar, J., McGovern, J., & Jagdeo, J. (2026). Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials. Journal of Drugs in Dermatology, 25(11), 1039-1044. https://doi.org/10.36849/jdd.10039
Vancouver
Joerg L, Stolyar J, McGovern J, Jagdeo J. Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials. Journal of Drugs in Dermatology. 2026;25(11):1039-1044. doi:10.36849/jdd.10039
BibTeX
@article{Joerg2026,
author = {Joerg, Lucie and Stolyar, Julia and McGovern, John and Jagdeo, Jared},
title = {Bruton Tyrosine Kinase Inhibitors for Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {11},
pages = {1039--1044},
doi = {10.36849/jdd.10039}
}
EUVIMED